Cancer-derived EVs carry a diverse number of nucleic acids, proteins, and lipids, such as microRNAs, mutated epidermal growth factor receptors (EGFR), and vascular endothelial growth factors (VEGF), that facilitate intercellular signaling, immune modulation, and the advancement of aggressive phenotypes (12–14). The gene discussed is VEGFA; the disease is cancer.